@article{JTD24843,
author = {Yuki Matsumura and Yuki Owada-Ozaki and Hiroyuki Suzuki},
title = {Significance of testing for TP53 gene mutations in lung adenocarcinoma using targeted gene sequencing},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 33},
year = {2018},
keywords = {},
abstract = {Randomized clinical trials have demonstrated the positive effects of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for patients with advanced or recurrent lung adenocarcinomas harboring EGFR gene mutations (1-3). Detecting cancer-specific gene mutations and exploring their targeted therapies for advanced non-small cell lung cancer (NSCLC) have therefore become a major topic of discussion over the past decade.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/24843}
}